Literature DB >> 8348164

A comparative study of human chorionic gonadotropin, placebo, and bed rest for women with early threatened abortion.

R F Harrison1.   

Abstract

OBJECTIVE: To compare the effect of hCG therapy with placebo or bed rest in women with threatened abortion.
DESIGN: Random assignment, double-blind.
SETTING: Community hospitals. PATIENTS AND
INTERVENTIONS: Sixty-one women with viable pregnancies under 8 weeks' gestation on admission to hospital were randomly allocated to receive injections of hCG or placebo, or were advised to rest in bed. MAIN OUTCOME MEASURES: Abortion vs. continuation of pregnancy at 16 weeks' gestation.
RESULTS: Thirty-one aborted: 6/20 on hCG, 10/21 on placebo, 15/20 on bed rest. hCG vs. bed rest, P < .01; placebo vs. bed rest, hCG vs. placebo--not significant. Plasma progesterone: continuing pregnancy > abortion, P < .01; continued with hCG vs. aborted on placebo, P < .001; continued with hCG vs. aborted with bed rest, P < .001. No significant differences in pregnancy/birth complications or infants' birth weight. Female/male ratio was 2:1.
CONCLUSIONS: hCG is significantly better than bed rest.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348164

Source DB:  PubMed          Journal:  Int J Fertil Menopausal Stud        ISSN: 1069-3130


  4 in total

Review 1.  Threatened miscarriage: evaluation and management.

Authors:  Alexandros Sotiriadis; Stefania Papatheodorou; George Makrydimas
Journal:  BMJ       Date:  2004-07-17

Review 2.  Bed rest during pregnancy for preventing miscarriage.

Authors:  A Aleman; F Althabe; J Belizán; E Bergel
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 3.  Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure.

Authors:  S Meher; L Duley
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

4.  A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial.

Authors:  Diana Man Ka Chan; Ka Wang Cheung; Sofie Shuk Fei Yung; Vivian Chi Yan Lee; Raymond Hang Wun Li; Ernest Hung Yu Ng
Journal:  Trials       Date:  2016-08-17       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.